Media Contact:

Julie A. Fotheringham - Partner, Hageman Communications  416-951-7988



Interface Biologics Enters the Neurology Market with 510(k) Clearance of Arkis BioSciences® CerebroFlo™ EVD Catheter with Endexo® Technology
Interface Biologics Inc. ("IBI"), a privately held, commercial stage company developing innovative material science technologies that save lives and improve patient outcomes, is pleased to announce that Arkis BioSciences® has received 510(k) clearance from U.S. Food and Drug Administration (FDA) for its exclusive CerebroFlo™ EVD Catheter with IBI's Endexo® technology.
Outcomes in a nurse-led peripherally inserted central catheter program: a retrospective cohort study published in CMAJ open
AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today the publication of a nurse-led, peripherally inserted central catheter (PICC) study in the July 4, 2017 edition of CMAJ Open, an online medical and health research journal of the Canadian Medical Association.
U of T inventor-entrepreneur honoured with Governor General’s Innovation Award
The molecules he works with are so small they can’t be seen with the naked eye, but for Professor Paul Santerre, who is being honoured with the 2017 Governor General’s Innovation Award, it’s what you do with those molecules that counts. One of six awardees to be recognized at a special ceremony at Rideau Hall on May 23, Santerre’s award recognizes his sweeping entrepreneurial vision for scientific inquiry — and its vital role in shaping Canada’s innovation economy.
Powered by Innovasium